Close Menu

MDxHealth

Genomic Health Publishes Development, Validation Studies on Oncotype DX Prostate Cancer Dx
Genomic Health has published in European Urology data from three studies involving its 17-gene Oncotype DX prostate cancer test.

NEW YORK (GenomeWeb) – MDxHealth said today that American Pathology Partners will promote and co-market the firm's ConfirmMDx for Prostate Cancer test in the US.

NEW YORK (GenomeWeb) – MDxHealth today reported a 36 percent year-over-year increase in its first quarter revenues as sales of its prostate cancer test grew nearly five-fold.

NEW YORK (GenomeWeb) – MDxHealth today announced an agreement with preferred provider organization Galaxy Health Network to provide access to MDxHealth's ConfirmMDx for Prostate Cancer test.

NEW YORK (GenomeWeb News) – MDxHealth today said that it has signed a co-marketing agreement with Long Island Pathology to promote MDxHealth's ConfirmMDx for Prostate Cancer test.

NEW YORK (GenomeWeb News) – MDxHealth today reported a 24 percent drop in revenues for its fourth quarter.

NEW YORK (GenomeWeb News) – MDxHealth today said that it has signed an agreement with preferred provider organization Prime Health Services to offer its ConfirmMDx for Prostate Cancer test to Prime Health's members.

MDxHealth this week publish the case study of a 63-year-old man whose prostate cancer was diagnosed with the help of its ConfirmMDx epigenetic test and a transperineal mapping biopsy, after five standard biopsies and an MRI failed to detect the disease.

NEW YORK (GenomeWeb News) – Teva Pharmaceuticals will be the exclusive distributor of MDxHealth's tests for prostate cancer and glioblastoma in Israel under a deal announced today.

NEW YORK (GenomeWeb News) – MDxHealth said today that it has signed up two additional US health insurance providers to cover its prostate cancer test.

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.